Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications
8.0
来源：
Nature
关键字：
ADC
发布时间：
2025-11-08 03:54
摘要：
Atypical intraductal proliferation (AIP) is identified as a critical diagnostic grey zone in prostate biopsies, indicating a potential risk for aggressive prostate cancer. The study highlights that AIP often coexists with intermediate-risk prostate cancer and shares molecular characteristics with intraductal carcinoma, suggesting its role in risk stratification. The findings advocate for enhanced precision diagnostics and active surveillance strategies in prostate cancer management.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
0.5
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.0
technical_barrier_competition
0.0
关键证据
AIP is a strong predictor of unsampled IDC and other adverse pathological features.
AIP frequently coexists with intermediate-risk prostate cancer and shares molecular alterations with IDC.
Understanding the implications of AIP is particularly relevant in the context of precision diagnostics.
真实性检查
否
AI评分总结
Atypical intraductal proliferation (AIP) is identified as a critical diagnostic grey zone in prostate biopsies, indicating a potential risk for aggressive prostate cancer. The study highlights that AIP often coexists with intermediate-risk prostate cancer and shares molecular characteristics with intraductal carcinoma, suggesting its role in risk stratification. The findings advocate for enhanced precision diagnostics and active surveillance strategies in prostate cancer management.